A new study published in the journal of Respiratory Medicine showed a strong correlation between a higher risk of chronic ...

Dupixent, which was rejected by the FDA for chronic spontaneous urticaria in October 2023, is now approved as the first new ...

Patients with COPD and established cardiovascular disease have more MACEs and seek less preventive cardiac care than patients with CVD alone.

Climate change is affecting the health of all individuals and represents an even more significant health risk for individuals with COPD.

E-cigarette use is linked to increased risk of COPD and possibly hypertension, though less harmful than traditional smoking, ...

chronic obstructive pulmonary disease (COPD), and ... How a New Gut Microbe Drives the Gut-Lung Axis Dec. 19, 2024 — A team has discovered a new communication pathway between the gut and lung.

A new study from University Hospitals Connor Whole Health found that it was feasible to conduct a hybrid music therapy ...

A new study has concluded that a blood test can identify whether the body’s organs are aging faster than expected ...

Cantor Fitzgerald initiated coverage of Verona Pharma (VRNA) with an Overweight rating and $80 price target The firm considers Verona one of ...

Chronic spontaneous urticaria is chronic inflammatory skin disease driven in part by type 2 inflammation, which causes sudden ...

Sanofi and Regeneron's Dupixent (dupilumab) has been approved by the FDA for the treatment of chronic spontaneous urticaria ...